Search General Info

2020 Schedule & Agenda

Check back regularly for new updates and announcements about the 2020 BIO International Convention schedule and agenda.

BIO International Convention
Date
  • Show All
Time
  • Show All
  • Show All
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Sessions
BIO International Convention
Jump to Day
69 Results
Available On-Demand
As the industry continues its shift from volume to value, stakeholders are increasingly relying on…
Click video to start playback;Join chat Q&A below video
While the impact of cardiovascular disease remains a major cause of mortally and morbidity, not…
Click video to start playback;Join chat Q&A below video
While artificial intelligence (AI) is providing meaningful advances across different industries,…
Click video to start playback;Join chat Q&A below video
The healthtech marketplace is one where few companies have a majority control of the distribution…
Click video to start playback;Join chat Q&A below video
Millions of people around the world are impacted by neurodegenerative diseases— the two most common…
Click video to start playback;Join chat Q&A below video
Iinnovation in the development of vaccines is not just limited to the vaccine itself. Over the last…
Click video to start playback;Join chat Q&A below video
The number and kind of global infectious disease outbreaks have increased significantly during the…
Click video to start playback;Join chat Q&A below video
Precision medicine was supposed to deliver more targeted, personalized treatment to all patients —…
Click video to start playback;Join chat Q&A below video
Commercially available CAR-T products such as Yescarta and Kymriah have shown the power of cell…
Click video to start playback;Join chat Q&A below video
Innovative medicines are increasingly coming to market with new modalities authorized under new…
Click video to start playback;Join chat Q&A below video
Is there a secret recipe for successful partnerships between founders and their investment partners…
Click video to start playback;Join chat Q&A below video
Many of the 7,000 rare diseases worldwide lack a standardized diagnostic test. Without a reliable…
Click video to start playback;Join chat Q&A below video
The CNS drug field has been hampered by trial failures in areas of substantial unmet medical need…
Click video to start playback;Join chat Q&A below video
While most of the attention in the use of digital health for chronic care management has gone to…
Click video to start playback;Join chat Q&A below video
Genomics is at an inflection point. Dramatic declines in the cost of sequencing combined with…
Click video to start playback;Join chat Q&A below video
Damage caused by opioid misuse and addiction reaches across every domain, from lost productivity…
Click video to start playback;Join chat Q&A below video
Initiatives to reduce opioid prescription and opiod use are in force, but the need for effective…
Click video to start playback;Join chat Q&A below video
The diverse panelists will lead a discussion of why and how to continue to increase inclusion and…
Click video to start playback;Join chat Q&A below video
The repurposing of existing drugs is an established approach to develop new treatment options for…
Click video to start playback;Join chat Q&A below video
Threats to U.S. technology from foreign sources have been in the news recently with reports of…
Click video to start playback;Join chat Q&A below video
Value based contracting approaches, which need to be informed by real-world evidence, become…
Click video to start playback;Join chat Q&A below video
Dr. Phil Febbo was appointed as Chief Medical Officer in March 2018. In this role, he is…
Click video to start playback;Join chat Q&A below video
Bioartificial organs have become viable therapies for life threatening diseases thanks to new…
Click video to start playback;Join chat Q&A below video
Panelists will feature academics and industry thought leaders as they share their expertise in…
Click video to start playback;Join chat Q&A below video
What if patients were not patients anymore? For companies developing gene therapies for rare…
Click video to start playback;Join chat Q&A below video
Genomic medicine is already heralding a new era of healthcare, bringing fresh hope to patients as…
Click video to start playback;Join chat Q&A below video
As the promise of innovation reveals to us a future of more targeted therapies, advanced biologics…
Click video to start playback;Join chat Q&A below video
With thousands of cancer drugs in the pipeline, and oncology drugs dominating annual lists of top…
Click video to start playback;Join chat Q&A below video
Bio/pharma transactions come in all shapes and sizes but each will have some element of IP due…
Click video to start playback;Join chat Q&A below video
In oncology, going beyond the current standard of care will require increasingly potent therapies -…
Click video to start playback;Join chat Q&A below video
Bio/pharma companies negotiate and enter into a multiplicity of contracts as a key part of company…
Click video to start playback;Join chat Q&A below video
The liquid biopsy market is expected to grow to as much as $30 billion by 2025. Many factors are…
Click video to start playback;Join chat Q&A below video
Biologics have revolutionized treatment for serious diseases and profoundly impacted millions of…
Click video to start playback;Join chat Q&A below video
The COVID-19 pandemic has stretched the limits of pharmaceutical development and manufacturing due…
Click video to start playback;Join chat Q&A below video
Cries for economic reform to halt the collapse of the antibiotics market have never been louder. As…
Click video to start playback;Join chat Q&A below video
Small businesses are constantly on the lookout for funding opportunities to meet their development…
Click video to start playback;Join chat Q&A below video
Biotechnology companies face multiple risks which, if not properly managed, can threaten their…
Click video to start playback;Join chat Q&A below video
Congress and the White House have seemed at odds on many positions but united in at least one –…
Click video to start playback;Join chat Q&A below video
It is well documented that clinical trials in the U.S. lack appropriate diverse representation…
Click video to start playback;Join chat Q&A below video
In the first three quarters of 2019, drug developers pledged to spend $182bn on M&A, beating the…
Click video to start playback;Join chat Q&A below video
“The microbiome” is everywhere in the press and fast-increasing resources are devoted to it in labs…
Click video to start playback;Join chat Q&A below video
The rise of Chinese bio and pharma companies has provided many US and European companies with the…
Click video to start playback;Join chat Q&A below video
Big Pharma and investors are closely watching the precision oncology space. From 2015 through 2019,…
Click video to start playback;Join chat Q&A below video
Mitochondria are known as the powerhouses and energy hubs of the cell. Mostly relegated to biology…
Click video to start playback;Join chat Q&A below video
The field of immuno-oncology has grown exponentially, leading to a host of new therapeutics being…
Click video to start playback;Join chat Q&A below video
The human microbiome is considered as the “new organ”, thought to be associated with multiple…
Click video to start playback;Join chat Q&A below video
The shortcomings of animal disease models are well known. More than 90% of drugs fail in early…
Click video to start playback;Join chat Q&A below video
In times of the Covid-19 pandemic, Biotech- and Pharmaindustry and public institutions are working…
Click video to start playback;Join chat Q&A below video
Cell and gene therapy (CGT) offers new hope for patients. There are essential differences between…
Click video to start playback;Join chat Q&A below video
The DTx market has grown more than 50% over the last 3 years, with many new technologies entering…
Click video to start playback;Join chat Q&A below video
Cell and gene therapies are transforming patients’ lives and payment models. This panel explores…
Click video to start playback;Join chat Q&A below video
In oncology, precision medicine is leading a paradigm shift away from a “one size fits all”…
Click video to start playback;Join chat Q&A below video
Bring a team of behavioral/neurobiology, neuroepigeneticists, and psychiatry clinician to discuss…
Click video to start playback;Join chat Q&A below video
Cures to devastating diseases, such as Hepatitis C drugs and gene therapies, are being developed…
Click video to start playback;Join chat Q&A below video
The latest UN estimates show men slightly outnumber women globally, but the future of biopharma is…
Click video to start playback;Join chat Q&A below video
What if we could halt or reverse the diseases associated with aging and extend the amount of…
Click video to start playback;Join chat Q&A below video
What is driving/sustaining the widest and longest-open IPO window, with 350 newly-public companies?…
Click video to start playback;Join chat Q&A below video
Ongoing innovation is needed to address the growing threat of antimicrobial resistance. The current…
Click video to start playback;Join chat Q&A below video
The role of the biotechnology sector in addressing global challenges has become clear during the…
Click video to start playback;Join chat Q&A below video
Six of the top ten biggest selling biopharmaceuticals were acquired or in-licensed. In parallel,…
Click video to start playback;Join chat Q&A below video
Since their inception, biotech incubators and accelerators have matured in the resources offered to…
Click video to start playback;Join chat Q&A below video
With digital health, we strive to improve patient outcomes by uncovering actionable insights…
Click video to start playback;Join chat Q&A below video
In view of burgeoning healthcare needs, most governments aspire to reduce their healthcare expense…
Click video to start playback;Join chat Q&A below video
In its 40-year lifetime, the HIV epidemic has shifted from a death sentence to a manageable…
Click video to start playback;Join chat Q&A below video
In parallel to videoconference presentation tips, the power of delivering the right content is ever…
Click video to start playback;Join chat Q&A below video
For more than a decade governments, thought leaders and industry have called for but questioned the…
Click video to start playback;Join chat Q&A below video
For many patients with blood cancers and serious blood disorders, bone marrow transplant can be a…
Click video to start playback;Join chat Q&A below video
There is no shortage of innovation in the biotechnology industry, with stunning advances in…
Click video to start playback;Join chat Q&A below video
Patents are key assets of bio/pharma companies. At every step that a company takes - from the time…
Click video to start playback;Join chat Q&A below video